Citadel Advisors’s Gain Therapeutics GANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.3K Buy
+24,900
New +$54.2K ﹤0.01% 12413
2025
Q4
Sell
-373,558
Closed -$997K 13236
2025
Q3
$661K Buy
373,558
+211,742
+131% +$357K ﹤0.01% 8469
2025
Q2
$291K Buy
161,816
+142,797
+751% +$264K ﹤0.01% 9883
2025
Q1
$36.3K Buy
19,019
+7,407
+64% +$16.4K ﹤0.01% 12628
2024
Q4
$25.1K Buy
+11,612
New +$23.3K ﹤0.01% 13026
2024
Q2
Sell
-4,223
Closed -$15.9K 14708
2024
Q1
$15.9K Sell
4,223
-61,171
-94% -$254K ﹤0.01% 13157
2023
Q4
$214K Buy
65,394
+19,518
+43% +$54.3K ﹤0.01% 9829
2023
Q3
$148K Buy
45,876
+9,629
+27% +$36.5K ﹤0.01% 10376
2023
Q2
$162K Buy
36,247
+18,800
+108% +$91.8K ﹤0.01% 10210
2023
Q1
$84.1K Buy
+17,447
New +$71.3K ﹤0.01% 11498
2022
Q1
Sell
-13,029
Closed -$70K 14001
2021
Q4
$70K Buy
+13,029
New +$89.9K ﹤0.01% 13026

Other funds holding GANX